HIV/AIDS shillfactor.net

Doug Richman

Dr. Richman serves on the HIV Advisory Board of Achillion Pharmaceuticals, Inc., alongside other HIV luminaries Dr. John Mellors, Dr. David Ho, Dr. Robert 'Chip' Schooley and Dr. Richard Whitley. He also serves on the Clinical & Scientific Advisory Board for Anadys Pharmaceuticals (alongside Dr. Robert Schooley), the Scientific Advisory Board for Monogram Biosciences (along with Drs. Ho and Schooley), and the Scientific Advisory Board of Adventryx Pharmaceuticals.

Monogram Biosciences (formerly ViroLogic) manufactures and sells kits and assays for measuring resistance to HIV medicines.

Adventryx Pharma is in the development stages of an oral pyrophosphate analogue that inhibits reverse transcriptase of HIV and CMV viruses (think kinder, gentler foscarnet) trade marked as Thiovir.

Anadys Pharmaceuticals is in the discovery phase of developing an HIV entry inhibitor.

Achillion Pharmaceuticals has two HIV drugs in development: a NRTI "me-too" known as elvucitabine and inhibitors of the HIV nucleocapsid.

Dr. Richman's disclosure statement (added October '06) on the website of the International AIDS Society-USA (where he serves on the Board of Directors alongside Paul Volberding, Robert Schooley and his wife Connie Benson, Roy 'Trip' Gulick, Michael Saag, Joel Gallant and Judy Currier) notes that he serves as a paid consultant for the following HIV companies:

Achillion
Anadys
Bristol-Myers Squibb
Boehringer Ingelheim
Gilead
GlaxoSmithKline
Idenix
Merck
Monogram Biosciences
Pfizer
Roche-Trimeris
Tibotec-Virco (a subsidiary of Johnson & Johnson)

In a required disclosure upon the release of HIV Treatment Guidelines on behalf of the International AIDS Society-USA in 2004, Dr. Richman revealed that he had served as a paid consultant for the following HIV companies:

Abbott Laboratories
Bristol-Myers Squibb
Chiron
Gilead
GlaxoSmithKline
Merck
Novirio (now Idenix)
Pfizer
Roche-Trimeris
Takeda
Triangle
ViroLogic (now Monogram Biosciences)

*********************************************************************************************************************************************
*****************************************************************************************************************************************

NOTE: While the concerns of commercial bias, corruption and kick-backs expressed here are serious and well-documented, they in no way endorse or support a thesis which denies any of the following:

(1) That HIV is necessary in the causation of the immune deficiency syndrome called AIDS;
(2) That HIV antibody tests accurately diagnose HIV in up to 98% of infected individuals after 4-12 weeks of infection;
(3) That antiretroviral medicines, while far from perfect, improve immune function and can extend life;
(4) That HIV is heterosexually as well as homosexually transmitted;
(5) That condoms, when used properly, can prevent HIV transmission;
(6) That HIV/AIDS is one of many serious public health challenges in many regions of Africa, Asia, and the Caribbean.

This site brought to you as an informational service and was definitively not made possible by a grant or gift--"educational," "unrestricted," or otherwise--by the likes of GlaxoSmithKline, Gilead, Bristol-Myers Squibb, Abbott, Tibotec-Virco, Pfizer, Merck, Monogram, Triangle, Trimeris, Boehringer Ingelheim, Roche, Schering, Panacos, Pharmasset, Shire, Ortho Biotech, (Orchestra Therapeutics), (Tanox), Genentech, Takeda, Vertex, (Bayer Diagnostics), Siemens, Acambis, Achillion, Adventrx, Anadys, (AnorMed), Genzyme, Avexa, Depomed, Idenix, Koronis, Millenium, Progenics, (Therapy Edge), Advanced Biological Concepts, VirXSys, Human Genome Sciences or any of the rest.